[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.129.96. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Controversies in Neurology
May 2000

Treatment of Ocular Myasthenia

Author Affiliations
 

HACHINSKIVLADIMIRMD, DSc

Arch Neurol. 2000;57(5):753. doi:10.1001/archneur.57.5.753

OCULAR myasthenia distresses. The patients neither see well nor look their best because of ptosis, strabismus, and diplopia.

Agius argues that half of the patients with ocular myasthenia have electromyographic evidence of generalized neuromuscular dysfunction and that most go on to develop generalized weakness, especially in the first year. He advocates treating patients with ocular myasthenia and generalized electromyographic changes not only for symptomatic relief, but to suppress the immune response. He believes that failing to do so may set the stage for exacerbations and progression.

First Page Preview View Large
First page PDF preview
First page PDF preview
×